Form 4: Outset Medical Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Jean-Olivier Racine, Chief Technology Officer of Outset Medical, sold 8,306 shares of common stock to cover tax withholding obligations related to vesting RSUs.
Summary
- Jean-Olivier Racine, the Chief Technology Officer of Outset Medical, Inc., sold 8,306 shares of common stock on May 10, 2024.
- The sale was executed at a price of $3.27 per share.
- This transaction was to cover tax withholding obligations related to the vesting of 33,923 shares of common stock underlying RSUs.
- The RSUs were granted on June 22, 2021, January 26, 2022, and January 6, 2023, and were subject to accelerated vesting approved by the Compensation Committee in connection with Racine's departure.
- Racine also acquired 1,801 shares of Common Stock pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ('ESPP') for the purchase period of September 1, 2023 to February 29, 2024.
- Following the transaction, Racine beneficially owns 265,325 shares of Outset Medical, Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is primarily driven by tax obligations related to vesting RSUs and an ESPP purchase, rather than a discretionary decision reflecting on the company's prospects.
Positives
- Racine acquired 1,801 shares through the company's Employee Stock Purchase Plan, indicating confidence in the company.
Negatives
- The sale of shares by a high-ranking executive, even for tax purposes, could be perceived negatively by some investors.
Risks
- Executive departures can sometimes create uncertainty within a company.
- The sale of shares by an executive could be interpreted as a lack of confidence in the company's future performance, although in this case it is attributed to tax obligations.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. They are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects. Sales to cover tax obligations are generally viewed as less indicative of management sentiment than discretionary sales.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Technology Officer | Jean-Olivier Racine | TBD | TBD | Reporting person's departure |
Stakeholder Impact
- The sale of shares could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| June 22, 2021 | Date of one of the RSU grants to the reporting person. |
| January 26, 2022 | Date of one of the RSU grants to the reporting person. |
| January 6, 2023 | Date of one of the RSU grants to the reporting person. |
| September 1, 2023 | Start date of the Employee Stock Purchase Plan purchase period. |
| February 29, 2024 | End date of the Employee Stock Purchase Plan purchase period. |
| May 10, 2024 | Date of the stock sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.